About Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin
During the past decade, Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2021-02-23
2025-04-15
Recruiting
270
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
2020-08-27
2026-12-31
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin
According to Clinical.Site data, the most researched conditions in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are
"Diffuse Large B-cell Lymphoma" (1 trials) and "Solid Tumours" (1 trials). Many other conditions were trialed in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" in a lesser frequency.
Clinical Trials Intervention Types at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin
Most popular intervention types in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (1 trials), "Glofitamab" (1 trials), "Obinutuzumab" (1 trials), "Oxaliplatin" (1 trials) and "Rituxumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin
The vast majority of trials in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are
2 trials for "All" genders.
Clinical Trials Status at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin
Currently, there are NaN active trials in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".